Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05746143 · ClinicalTrials.gov registry record · Phase 4
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
A Phase 4 study of Pain, Postoperative and Lumbar Spine Degeneration, sponsored by University of Southern California.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT05746143: Recruiting Phase 4 study of Pain, Postoperative and Lumbar Spine Degeneration, sponsored by University of Southern California.
NCT05746143 is a Phase 4 study of Pain, Postoperative and Lumbar Spine Degeneration that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 140 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05746143, a Phase 4 study of Pain, Postoperative and Lumbar Spine Degeneration, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.
Primary Outcome
Visual analog scale (VAS) for back and leg pain; scale range: 0-10, higher scores = increased pain (worse outcome)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Zolpidem Tartrate 10 mg
Study Locations (1)
California
- Keck Medical Center of USC - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 4 |
What NCT05746143 shows while recruiting
NCT05746143 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (49% lower).
The record links to 4 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05746143 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05746143 about?
NCT05746143 is a clinical study titled "The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion". The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.
What is the current status of trial NCT05746143?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2022-02-01. Estimated completion is 2027-12-31.
What conditions does trial NCT05746143 study?
This clinical trial studies the following conditions: Pain, Postoperative, Lumbar Spine Degeneration, Spine Fusion, Lumbar Spine Spondylosis.
What interventions are being tested in trial NCT05746143?
The interventions under investigation include: Placebo (DRUG), Zolpidem Tartrate 10 mg (DRUG).
Who is sponsoring clinical trial NCT05746143?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05746143 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05746143's enrollment target sits among peer trials
140 31st of 113 higher than 83 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI